These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36203007)

  • 1. Molecular pathways of major depressive disorder converge on the synapse.
    Fries GR; Saldana VA; Finnstein J; Rein T
    Mol Psychiatry; 2023 Jan; 28(1):284-297. PubMed ID: 36203007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants.
    Pehrson AL; Sanchez C
    Drug Des Devel Ther; 2015; 9():603-24. PubMed ID: 25653499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.
    Pitsillou E; Bresnehan SM; Kagarakis EA; Wijoyo SJ; Liang J; Hung A; Karagiannis TC
    Mol Biol Rep; 2020 Jan; 47(1):753-770. PubMed ID: 31612411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Chemokines in the Pathophysiology of Major Depressive Disorder.
    Milenkovic VM; Stanton EH; Nothdurfter C; Rupprecht R; Wetzel CH
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31075818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.
    Quesseveur G; Gardier AM; Guiard BP
    Curr Drug Targets; 2013 Oct; 14(11):1277-94. PubMed ID: 24020973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurobiology of depression: An integrated view.
    Dean J; Keshavan M
    Asian J Psychiatr; 2017 Jun; 27():101-111. PubMed ID: 28558878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research.
    Amidfar M; Woelfer M; Réus GZ; Quevedo J; Walter M; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109668. PubMed ID: 31207274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimmune Advance in Depressive Disorder.
    Zhao G; Liu X
    Adv Exp Med Biol; 2019; 1180():85-98. PubMed ID: 31784958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical Exercise and Neuroinflammation in Major Depressive Disorder.
    Ignácio ZM; da Silva RS; Plissari ME; Quevedo J; Réus GZ
    Mol Neurobiol; 2019 Dec; 56(12):8323-8335. PubMed ID: 31228000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide: Antidepressant mechanisms and inflammation.
    Ghasemi M
    Adv Pharmacol; 2019; 86():121-152. PubMed ID: 31378250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression.
    Verduijn J; Milaneschi Y; Schoevers RA; van Hemert AM; Beekman AT; Penninx BW
    Transl Psychiatry; 2015 Sep; 5(9):e649. PubMed ID: 26418277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Pharmacological Interventions in Bipolar Disorder.
    Juruena MF; Jelen LA; Young AH; Cleare AJ
    Curr Top Behav Neurosci; 2021; 48():303-324. PubMed ID: 33547595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk.
    Srivastava A; Singh P; Gupta H; Kaur H; Kanojia N; Guin D; Sood M; Chadda RK; Yadav J; Vohora D; Saso L; Kukreti R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting 2-arachidonoylglycerol signalling in the neurobiology and treatment of depression.
    Silveira KM; Wegener G; Joca SRL
    Basic Clin Pharmacol Toxicol; 2021 Jul; 129(1):3-14. PubMed ID: 33905617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiology of major depressive disorder.
    Villanueva R
    Neural Plast; 2013; 2013():873278. PubMed ID: 24222865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAPON Is a Critical Protein in Synaptic Molecular Networks in the Prefrontal Cortex of Mood Disorder Patients and Contributes to Depression-Like Behavior in a Mouse Model.
    Gao S; Zhang T; Jin L; Liang D; Fan G; Song Y; Lucassen PJ; Yu R; Swaab DF
    Cereb Cortex; 2019 Aug; 29(9):3752-3765. PubMed ID: 30307500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.
    Kennedy SE; Koeppe RA; Young EA; Zubieta JK
    Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of proteomic studies in humans, animal models, and after antidepressant treatments to investigate the molecular neurobiology of major depression.
    Carboni L
    Proteomics Clin Appl; 2015 Oct; 9(9-10):889-98. PubMed ID: 25488430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating the serotonin system in the treatment of major depressive disorder.
    Morrissette DA; Stahl SM
    CNS Spectr; 2014 Dec; 19 Suppl 1():57-67; quiz 54-7, 68. PubMed ID: 25544378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.